CX Partners Fund II

Health

CX Partners is one of the most experienced mid-market private equity teams in India, with some of the Partners investing since 1996 (as part of Citi Venture Capital International) and delivering returns through identifying some of the early trends in sectors such as IT, generics pharma, private banks and consumer services. The fund manager has invested in leading businesses such as Thyrocare, Minacs, Ujjivan, SIS, Sutures India, Sapphire Foods etc.

Our investment

In May 2018, CDC committed $40 million and played a pivotal role in anchoring the first close for CX Partners II.

Expected impact

CX will invest and create value in high quality, scalable businesses, which provide employment and on-the-job training to a significant number of unskilled and semi-skilled workers.

Key facts

Status:
Active
Countries

For funds, the countries listed here are those the fund has invested in so far.

:
India
Sector

We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people. For funds, the sectors listed here are those the fund has invested in so far.

:
Health
Investment type

We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).

:
Intermediated investment
Fund manager:
CX Partners
Start date

For direct investments, this is the date CDC committed capital to the business or project.

For funds, this is the date that CDC committed capital to the fund.

For underlying fund investments, this is the date that the fund invested capital into the business.e

:
May 2018
Amount

For direct investments, this is the total amount that CDC has committed to the business or project (it may be a combination of equity and debt).

For funds, this is the total amount that CDC has committed to the fund.

:
$30m
Domicile

This is the investee company’s place of incorporation; or a fund’s jurisdiction.

:
Mauritius

Investments made by this fund

  • Active
  • Exited
Investment name Country Region Sector Start date Status
Veeda Clinical Research

Veeda offers analytical, biomarker and data management services to global pharmaceutical companies.

View investment details

India South Asia Health October 2018 Active